Skip to main content

Table 4 Laboratory and metabolomics findings in the other detected inborn errors of metabolism (amino acidopathies, fatty acids oxidation defects, and lactic acidemia

From: Inherited metabolic disorders in a cohort of Egyptian children

Defect

Laboratory findings

MS/MS profile of acylcarnitine

MS/MS profile of amino acids

Diagnostic metabolites

PKU

Metabolic acidosis

NR

High phe:tyr elevated phe

Phenyllactate, phenylpyruvate, phenylacetate (genetic assay for confirmation)

MSUD

Metabolic acidosis ketosis

NR

Elevated Leu/Ile and valine

Alloisoleucine 2-oxoisocaproate and 2-hydroxyisovalerate

Homocystinuria

 

NR

High methionine

Measurement of homocystine in blood was done for confirmation

Nonketotic hyperglycinemia

Hyperglycemia

NR

High glycine

Recommend measurement of Gly/CSF plasma ratio (this test was unavailable)

FAO defects

Metabolic acidosis hypoglycemia mostly without ketosis (hypoketotic hypoglycemia) with elevated lactate level elevated lactate to pyruvate ratio

Increase C6-C10

Low level of C16 and C18:1 and high C0 in one case

NR

Elevated dicarboxylic acids such as adipic, suberic, dehydrosuberic, sebacic, dehydrosebacic, and modest amounts of 3-OH dicarboxylics-hexanoyl glycine.

LA (after ruling out physiological causes)

Marked metabolic acidosis, high lactate

NR

NR

Elevated lactic acid

3 hydroxybuturic acid

4 hydroxyphenyllactic acid

4 hydroxyphenylpyruvic acid

Enzyme and molecular genetic studies should be carried out when available and related to the initial tests as well as the clinical findings

  1. PKU phenylketonuria, MSUD maple syrup urine disease, Phe:tyr phenylalanine: tyrosine ratio, Leu/Ile leucine:isoleucine, Gly glycine, CSF cereprospinal fluid, NR not remarkable, C0 Free carnitine, C6 Hexanoylcarnitine, C10 Decanoylcarnitine, C16 Hexadecanoylcarnitine, C18:1 Linoleoylcarnitine